{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:35Z","timestamp":1793224415236,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001194"],"award-info":[{"award-number":["FC001194"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.coi.2021.06.014","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T12:19:23Z","timestamp":1627906763000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["BAFF signaling in health and disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Edina","family":"Schweighoffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor LJ","family":"Tybulewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.06.014_bib0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","article-title":"TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS","volume":"15","author":"Gross","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005456","article-title":"Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells","volume":"4","author":"Rauch","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.06.014_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","article-title":"B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40265-018-0872-z","article-title":"Belimumab: a review in systemic lupus erythematosus","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.coi.2021.06.014_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fmed.2020.00303","article-title":"Belimumab and rituximab in systemic lupus erythematosus: a tale of two B cell-targeting agents","volume":"7","author":"Wise","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2021.06.014_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2017.10.002","article-title":"Signalling for B cell survival","volume":"51","author":"Schweighoffer","year":"2018","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.coi.2021.06.014_bib0040","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.celrep.2013.10.022","article-title":"Context-specific BAFF-R signaling by the NF-kappaB and PI3K pathways","volume":"5","author":"Jellusova","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2021.06.014_bib0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2012.11.015","article-title":"The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway","volume":"38","author":"Schweighoffer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.014_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","article-title":"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease","volume":"244","author":"Rickert","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2021.06.014_bib0055","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.4049\/jimmunol.179.6.3872","article-title":"Bruton\u2019s tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family","volume":"179","author":"Shinners","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0060","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","article-title":"Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL","volume":"180","author":"Benson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0065","doi-asserted-by":"crossref","first-page":"15517","DOI":"10.1073\/pnas.0807841105","article-title":"BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact","volume":"105","author":"Scholz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.06.014_bib0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.it.2011.09.001","article-title":"Staying alive: regulation of plasma cell survival","volume":"32","author":"Tangye","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.014_sbref0080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191393","article-title":"Critical requirement for BCR, BAFF, and BAFFR in memory B cell survival","volume":"218","author":"M\u00fcller-Winkler","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.014_sbref0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191167","article-title":"BAFFR controls early memory B cell responses but is dispensable for germinal center function","volume":"218","author":"Lau","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.014_bib0090","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.014_bib0095","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.014_bib0100","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.4049\/jimmunol.1501365","article-title":"Cellular dynamics of memory B cell populations: IgM+ and IgG+ memory B cells persist indefinitely as quiescent cells","volume":"195","author":"Jones","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.27189","article-title":"Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study","volume":"62","author":"Jacobi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2021.06.014_bib0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ebiom.2018.12.035","article-title":"B cell alterations during BAFF inhibition with belimumab in SLE","volume":"40","author":"Ramskold","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2021.06.014_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphar.2019.00433","article-title":"Association between changes in BLyS levels and the composition of B and T cell compartments in patients with refractory systemic lupus erythematosus treated with belimumab","volume":"10","author":"Regola","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coi.2021.06.014_bib0120","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2021.06.014_bib0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122525","article-title":"Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients","volume":"3","author":"Huang","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2021.06.014_bib0130","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/cncr.31931","article-title":"Chronic lymphocytic leukemia (CLL) treatment: so many choices, such great options","volume":"125","author":"Sharma","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.coi.2021.06.014_sbref0135","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3324\/haematol.2017.170571","article-title":"SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia","volume":"102","author":"Paiva","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2021.06.014_sbref0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/bloodadvances.2018025684","article-title":"Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib","volume":"3","author":"McWilliams","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2021.06.014_sbref0145","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.3390\/cancers12102725","article-title":"Neutralization of B-cell activating factor (BAFF) by belimumab reinforces small molecule inhibitor treatment in chronic lymphocytic leukemia","volume":"12","author":"Tandler","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.coi.2021.06.014_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2015.04.007","article-title":"Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers","volume":"61","author":"Figgett","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2021.06.014_bib0155","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.1600017","article-title":"Cutting edge: BAFF promotes autoantibody production via TACI-dependent activation of transitional B cells","volume":"196","author":"Jacobs","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_sbref0160","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.4049\/jimmunol.1800393","article-title":"Integrated B cell, toll-like, and BAFF receptor signals promote autoantibody production by transitional B cells","volume":"201","author":"Du","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_bib0165","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2007-08-106286","article-title":"Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the children\u2019s oncology group","volume":"111","author":"Fujii","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.06.014_bib0170","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coi.2021.06.014_bib0175","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood.2020008040","article-title":"BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation","volume":"137","author":"Jia","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.06.014_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112399","article-title":"BST-2\/Tetherin is involved in BAFF-enhanced proliferation and survival via canonical NF-kappaB signaling in neoplastic B-lymphoid cells","volume":"398","author":"Fu","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.coi.2021.06.014_bib0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Expert panel of the 27th annual meeting of the European Charcot F: role of b cells in multiple sclerosis and related disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2021.06.014_bib0190","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.5040-08.2009","article-title":"Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor","volume":"29","author":"Zhang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.coi.2021.06.014_sbref0195","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1038\/s41598-021-82346-6","article-title":"B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF","volume":"11","author":"Bakhuraysah","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2021.06.014_sbref0200","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1038\/s41598-019-49390-9","article-title":"TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells","volume":"9","author":"Whillock","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2021.06.014_sbref0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100465","article-title":"TNF receptor-associated factor 3 restrains B cell receptor signaling in normal and malignant B cells","volume":"296","author":"Whillock","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2021.06.014_sbref0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41419-020-03035-2","article-title":"BAFF-driven NLRP3 inflammasome activation in B cells","volume":"11","author":"Lim","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coi.2021.06.014_sbref0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.06.014_bib0220","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.1401514","article-title":"Conditional deletion of NF-kappaB-inducing kinase (NIK) in adult mice disrupts mature B cell survival and activation","volume":"195","author":"Brightbill","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.014_sbref0225","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41418-020-0496-1","article-title":"NF-kappaB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia","volume":"27","author":"Sanchez-Lopez","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2021.06.014_sbref0230","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1158\/1078-0432.CCR-18-1548","article-title":"BIRC3 expression predicts CLL progression and defines treatment sensitivity via enhanced NF-kappaB nuclear translocation","volume":"25","author":"Asslaber","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:47:43Z","timestamp":1760604463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":46,"alternative-id":["S0952791521000832"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.06.014","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BAFF signaling in health and disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}